You know the script. Take this, give it six weeks. The side effects show up in the first few days and the benefits maybe never do. At the follow-up your doctor tries something else, and the six weeks start again. Some people go through this three or four times. Many stop after the second.
In the largest real-world study of depression treatment, about a third of people reached remission on the first antidepressant. The rest moved on to the next one, and each round was allowed to run up to fourteen weeks. That is a long time to feel worse while waiting to feel better, and for a large share of people a good part of that time was spent on a dose that was never right for their body.
The dose you take is not the dose your body sees
Most antidepressants are cleared from your blood by two liver enzymes, CYP2C19 and CYP2D6. Escitalopram, citalopram and sertraline go through the first. Paroxetine, fluvoxamine and venlafaxine go through the second. How fast those enzymes run is set by your genes, and the range is wide. In one large clinical cohort, nearly half of patients were not normal metabolizers on CYP2D6 alone.
If your enzyme runs fast, a standard dose is cleared before it builds to a working level. You take it every day, feel nothing, and after six weeks the drug is declared a failure when it never really arrived. If your enzyme runs slow, the same dose piles up. You get the nausea, the fog, the sweats and the flat feeling at full strength, often within days, and you stop taking it because you feel worse. On paper both of you "did not respond." In practice one of you was underdosed and one of you was overdosed, and neither of you was told.
The guidelines already exist
This is not speculative. The Clinical Pharmacogenetics Implementation Consortium, the body that writes gene-based prescribing guidance, updated its antidepressant guideline in 2023. It tells doctors that slow CYP2C19 metabolizers should start escitalopram or sertraline at half the usual dose or use a different drug, that fast metabolizers may not respond to standard doses at all, and that slow CYP2D6 metabolizers should avoid paroxetine or halve it. The recommendations are specific, drug by drug and genotype by genotype.
They are almost never used, because when the prescription is written, nobody in the room knows your genotype. The test exists. The guideline exists. The information about you is the missing piece, and the way it currently gets discovered is six weeks at a time.
What your DNA adds
Your genome contains both enzymes. Read before the first prescription, it lets your doctor start from the guideline instead of from the default, which means the first drug and the first dose are chosen for your body rather than for the average one. You do not skip the wait entirely. You skip the rounds that were never going to work.
It also rewrites your history. If an antidepressant made you feel terrible in week one, or did nothing at all in week eight, your genome can tell you whether that was the drug or the dose. A lot of people have concluded that antidepressants do not work for them on the strength of one or two trials that were mismatched from the start. That conclusion is worth checking.
There is an honest limit here. Metabolism is not the whole story of why a drug helps one person and not another, and trials of gene-guided prescribing show real but modest gains: fewer prescriptions that clash with a patient's genotype, and somewhat better early remission rates, not a guarantee. What the genome does is remove one of the reasons a good drug fails. Given that the alternative is finding out by trial and error while you are at your lowest, removing that reason is worth a great deal.
What to do with it
Your next prescription. Bring your metabolizer results to whoever prescribes for you, before the next drug or dose change. Ask them to check the CPIC guideline for the drug they are considering. Most will know it, and the ones who do not can read it in five minutes.
Your past prescriptions. Look at the drugs that failed or that you could not tolerate, and check them against your genotype. A drug that "did not work" at a dose your body could not hold may deserve a second look at a different dose.
Your other medications. The same enzymes clear painkillers, acid reducers and many other drugs, and some of those drugs slow the enzymes down. Your genome plus your medicine cabinet is the full picture, and your prescriber needs both.
Your future self. Pharmacogenetics is one of the fastest-moving areas in medicine. New drug and gene pairs are added to the guidelines every year, and each one is applied to your sequence as it lands, without another swab.
This is information rather than a diagnosis. Do not stop, start or change an antidepressant on your own; the conversation belongs with your prescriber. If you are struggling right now, that conversation is worth having this week rather than after the next six weeks.
The same reading, everywhere else
The two enzymes behind this post are the same ones that decide whether codeine works on you after surgery and how you handle dozens of other common prescriptions. They sit in your genome alongside the genes that set how you respond to caffeine, how your skin ages and how your body handles alcohol. You read all of it once.
Lifecode reads all 6.4 billion letters and re-reads them as the science improves. That is why we built it.
Read your own genome.
Order your genome